CID1670

A genome-wide association study (GWAS) of dry eye (DE) suggests DE-associated single nucleotide polymorphisms (SNPs) are correlated with increased ocular pain and comorbidities, but not with DE signs, according to study...

Several significant advances have occurred in dry eye disease (DED) treatment in recent years, according to Amy Lin, MD. Including treatments with novel mechanisms of action and delivery systems. “This news is very exciting for...

When virtual schooling became the new norm during the COVID-19 pandemic, ophthalmologists predicted an increase in digital eye strain in children. Study results have confirmed that the increased screen time did lead to more eye...

In a randomized, triple-blind, phase II clinical trial, investigators sought to determine the effectiveness of a subconjunctival novel sirolimus liposomal formulation for treating dry eye. The study, which included 19 patients...

New treatments are needed to improve the signs and symptoms of dry eye, according to researchers who conducted the ONSET-2 phase III trial, which randomized 758 subjects 1:1:1 to placebo, 0.6 mg/mL OC-01 (Varenicline) nasal...

The world’s largest gathering of ophthalmologists kicking off tomorrow. The American Academy of Ophthalmology® will hold its 2021 Annual Meeting November 12-15, 2021, in New Orleans, with on-demand sessions available. The...

For this year’s American Academy of Ophthalmology annual meeting, the AAO organization has created the following health and safety requirements as they are committed to the health and well-being of meeting attendees,...

To assess the role of conditioned pain modulation (CPM), a measure of inhibitory pain pathways, in dry eye management (DE), researchers conducted a cross-sectional study of 268 patients from October 2017 to August 2018. They...